Latest filing published 14 Aug 2026 for Orchestra BioMed Holdings, Inc., €14k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
David Pacitti, listed as chief executive, has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Avanos Medical, Inc., Orchestra BioMed Holdings, Inc. and Apollo Endosurgery, Inc. Between 19 May 2021 and 12 August 2026, the trades on record add up to 19 filings.
The open-market record consists of 2 sales worth €6,546, with no purchase. Outside the open market, there are 14 share grants.
The record was last updated on 14 August 2026 with a share grant (€14k) in Orchestra BioMed Holdings, Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
19 of 19 declarations